Terms: = Pancreatic cancer AND JAK3, L-JAK, 3718, ENSG00000105639, P52333, JAKL, JAK-3, LJAK, JAK3_HUMAN AND Treatment
4 results:
1. Single-cell RNA-seq analyses inform necroptosis-associated myeloid lineages influence the immune landscape of pancreas cancer.
Dong W; Zhao H; Xiao S; Zheng L; Fan T; Wang L; Zhang H; Hu Y; Yang J; Wang T; Xiao W
Front Immunol; 2023; 14():1263633. PubMed ID: 38149248
[TBL] [Abstract] [Full Text] [Related]
2. Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced pancreatic cancer: A Systematic Review and Meta-Analysis.
Chiramel J; Backen AC; Pihlak R; Lamarca A; Frizziero M; Tariq NU; Hubner RA; Valle JW; Amir E; McNamara MG
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28445400
[TBL] [Abstract] [Full Text] [Related]
3. EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer.
Tang SN; Fu J; Shankar S; Srivastava RK
PLoS One; 2012; 7(2):e31067. PubMed ID: 22348037
[TBL] [Abstract] [Full Text] [Related]
4. Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls.
Pedersen KS; Bamlet WR; Oberg AL; de Andrade M; Matsumoto ME; Tang H; Thibodeau SN; Petersen GM; Wang L
PLoS One; 2011 Mar; 6(3):e18223. PubMed ID: 21455317
[TBL] [Abstract] [Full Text] [Related]
